Furthermore, TAM-derived SPARC, cathepsins, and TGF-β collectively facilitate epithelial–mesenchymal transition (EMT), angiogenesis, and immune evasion, subsequently driving tumor progression [37,38,39]. The gene discussed is TGFB1; the disease is neoplasm.